Aytu biopharma announces publication of data demonstrating ultraviolet-a light reduces cellular cytokine release from human endotracheal cells infected with coronavirus

Englewood, co / accesswire / july 27, 2021 / aytu biopharma, inc. (nasdaq:aytu), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, announced today that data from a laboratory study evaluating the ultraviolet a light used in the healight™ endotracheal catheter technology was published in the peer reviewed journal photodiagnosis and photodynamics therapy. "these latest in vitro findings continue to build upon the body of scientific evidence supporting the potential of this uva platform technology and may help to explain the observed effects of healight in sars-cov-2.
AYTU Ratings Summary
AYTU Quant Ranking